BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial

Trial StartPhasix™ MeshPositive

AI Analysis

Summary

BD announced completion of enrollment in the PREVENT trial, a large-scale randomized study evaluating Phasix™ Mesh for incisional hernia prevention following abdominal surgery, addressing a significant unmet clinical need.

Clinical Trial Data

Outcome Details

Enrollment completed in PREVENT trial

Importance:6/10

Sentiment:

0.60

tissue regenerationhernia preventionclinical trialenrollment completeabdominal surgery

Related Companies

$BDX

Read the original article

Published by PR Newswire Biotech on August 12, 2026 10:50 AM

Read Original